For over 1 million adults and children in the United States who suffer from inflammatory bowel disease (IBD), symptoms such as abdominal pain, digestive issues, weight loss and fatigue are an uncomfortable way of life, even with treatment. IBD (a term for two conditions, Crohn’s disease and ulcerative colitis), shows up as chronic inflammation of the gastrointestinal tract. The exact cause of IBD is unknown, but the disease results from a defective immune system.
Trending
- Colorectal cancer screening: An update to the American Cancer Society guideline, 2026 (American Cancer Society Journals)
- ‘Expanding the Funnel’: How Alternate Screening Methods Could Boost ASC GI Volumes (ASC News)
- Short-term profits or long-term health? ACP sounds warning on private equity in health care (Medical Economics)
- EoE Treatments Abound—If It’s Diagnosed Accurately (GI & Endoscopy News)
- Endoscopic drug depots for chronic GI Disease: A conversation with Edulis Therapeutics (GI & Hepatology News)
- Artificial intelligence-assisted endoscopists improve the detection rate of high-risk gastric lesions: A propensity score-matched retrospective study (World Journal of Gastroenterology)
- 5 GI power players (Becker’s GI & Endoscopy)
- Unio Health Partners and Thesis Care Announce Partnership to Scale AI-Powered Clinical Teams Across Specialty Care (Business Wire)
